Medicare Enrolled

Dr. Rafid Kouz, MD.

Hematology & Oncology · Mission Hills, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
11333 SEPULVEDA BLVD, Mission Hills, CA 91345
8183659531
In practice since 2006 (19 years)
NPI: 1346272994 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Kouz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kouz? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Kouz

Dr. Rafid Kouz is a hematology & oncology specialist in Mission Hills, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Kouz performed 677 Medicare services across 300 unique beneficiaries.

Between the years covered by Open Payments, Dr. Kouz received a total of $13,209 from 56 pharmaceutical and/or device companies across 450 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Kouz is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ 677 Medicare services $13,209 industry payments

Medicare Practice Summary

Medicare Utilization ↗
677
Medicare services
Bottom 42% in CA for hematology & oncology
300
Unique beneficiaries
$59
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~36 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
297 $8 $10
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
268 $100 $378
New patient office visit, complex (60-74 min) 41 $163 $645
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
39 $12 $44
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
16 $50 $268
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
16 $148 $528
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$13,209
Total received (2018-2024)
Avg $1,887/year across 7 years
Top 28% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
56
Companies
450
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,639 (57.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,746 (35.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$824 (6.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,285
2023
$3,166
2022
$2,211
2021
$546
2020
$1,072
2019
$1,738
2018
$1,191

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$883
Merck Sharp & Dohme LLC
$405
PFIZER INC.
$262
Gilead Sciences, Inc.
$222
Celgene Corporation
$197
Janssen Biotech, Inc.
$168
Astellas Pharma US Inc
$107
EMD Serono, Inc.
$94
ADC Therapeutics America, Inc.
$87
E.R. Squibb & Sons, L.L.C.
$79
Genentech USA, Inc.
$73
Daiichi Sankyo Inc.
$56
GENZYME CORPORATION
$55
Bayer Healthcare Pharmaceuticals Inc.
$54
Lilly USA, LLC
$51
Aveo Pharmaceuticals, Inc.
$51
Coherus Biosciences Inc.
$49
Stemline Therapeutics Inc.
$39
Eisai Inc.
$37
Agios Pharmaceuticals, Inc.
$35
Mirati Therapeutics, Inc.
$33
Regeneron Healthcare Solutions, Inc.
$32
Karyopharm Therapeutics Inc.
$32
Alexion Pharmaceuticals, Inc.
$30
GlaxoSmithKline, LLC.
$30
Kite Pharma, Inc.
$27
Deciphera Pharmaceuticals Inc.
$23
JAZZ PHARMACEUTICALS INC.
$22
Rigel Pharmaceuticals, Inc.
$18
Takeda Pharmaceuticals U.S.A., Inc.
$16
ARRAY BIOPHARMA INC
$14
Top 3 companies account for 47.2% of 2024 payments
All-time payments by company (2018-2024) ›
Kite Pharma, Inc.
$3,258
AstraZeneca Pharmaceuticals LP
$1,739
PFIZER INC.
$777
E.R. Squibb & Sons, L.L.C.
$654
SANOFI-AVENTIS U.S. LLC
$650
Merck Sharp & Dohme LLC
$640
Seagen Inc.
$569
Celgene Corporation
$377
Gilead Sciences, Inc.
$373
Janssen Biotech, Inc.
$298
Genentech USA, Inc.
$267
Bayer HealthCare Pharmaceuticals Inc.
$254
Amgen Inc.
$252
Merck Sharp & Dohme Corporation
$240
Seattle Genetics, Inc.
$205
GENZYME CORPORATION
$167
Astellas Pharma US Inc
$166
EMD Serono, Inc.
$153
Mirati Therapeutics, Inc.
$132
Takeda Pharmaceuticals U.S.A., Inc.
$114
Novartis Pharmaceuticals Corporation
$113
Medtronic USA, Inc.
$113
Daiichi Sankyo Inc.
$101
COMSORT, Inc
$100
Alexion Pharmaceuticals, Inc.
$99
Regeneron Healthcare Solutions, Inc.
$95
ADC Therapeutics America, Inc.
$87
Eisai Inc.
$79
Bayer Healthcare Pharmaceuticals Inc.
$78
JAZZ PHARMACEUTICALS INC.
$74
Exelixis Inc.
$68
Deciphera Pharmaceuticals Inc.
$67
Clovis Oncology, Inc.
$62
Incyte Corporation
$53
Lilly USA, LLC
$51
Ipsen Biopharmaceuticals, Inc
$51
Aveo Pharmaceuticals, Inc.
$51
Coherus Biosciences Inc.
$49
Allergan Inc.
$48
MEDIVATION FIELD SOLUTIONS LLC
$44
TOLMAR Pharmaceuticals, Inc.
$39
Stemline Therapeutics Inc.
$39
AVEO Pharmaceuticals, Inc.
$38
Agios Pharmaceuticals, Inc.
$35
Karyopharm Therapeutics Inc.
$32
Taiho Oncology, Inc.
$31
GlaxoSmithKline, LLC.
$30
ImmunoGen, Inc.
$29
Alnylam Pharmaceuticals Inc.
$26
TESARO, Inc.
$25
Boehringer Ingelheim Pharmaceuticals, Inc.
$23
Pharmacyclics LLC, An AbbVie Company
$23
Epizyme, Inc.,
$20
Rigel Pharmaceuticals, Inc.
$18
TG THERAPEUTICS, INC.
$16
ARRAY BIOPHARMA INC
$14
Top 3 companies account for 43.7% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · ALLODERM · Abraxane · Avastin · BAVENCIO · BOSULIF · Blincyto · CABOMETYX · CALQUENCE · Cabometyx · DARZALEX · ELIGARD · ELIQUIS · ELREXFIO · EMPLICITI · ENHERTU · Elahere · Enhertu · Erleada · FASLODEX · FOTIVDA · FRUZAQLA · GILOTRIF · GIVLAARI · IBRANCE · IMFINZI · INLYTA · INREBIC · Imbruvica · Inrebic · Intact · Itovebi · JAKAFI · JEMPERLI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LORBRENA · LYNPARZA · LYRICA · Lenvima · Lonsurf · Lunsumio · MEKINIST · MYLOTARG · Nplate · Nubeqa · OPDIVO · OPDUALAG · Onivyde · Orserdu · PADCEV · PIQRAY · PROMACTA · PYRUKYND · Perjeta · PlasmaBlade · QINLOCK · REBLOZYL · RYBREVANT · Revlimid · Rezlidhia · Rubraca · SARCLISA · SUTENT · SYMBICORT · Stivarga · TAGRISSO · TALZENNA · TAZVERIK · TECENTRIQ · TECVAYLI · TIVDAK · TUMOR LYSIS SYNDROME - DISEASE · Tecartus · Trodelvy · UKONIQ · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · Vyloy · XALKORI · XOSPATA · XPOVIO · XTANDI · Xofigo · Xospata · Yescarta · ZEJULA · ZEPZELCA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (58%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a hematology & oncology specialist in Mission Hills?
Compare hematology & oncology specialists in the Mission Hills area by procedure volume, costs, and industry payment transparency.
Browse hematology & oncology specialists nearby

Geographic Context

Hematology & oncology specialists within 10 mi
286
Per 100K population
2.9
County median income
$87,760
Nearest hospital
KAISER FOUNDATION HOSPITAL - PANORAMA CITY
3.1 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Kouz is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Kouz experienced with blood draw (venipuncture)?
Based on Medicare claims data, Dr. Kouz performed 297 blood draw (venipuncture) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kouz receive payments from pharmaceutical companies?
Yes. Dr. Kouz received a total of $13,209 from 56 companies across 450 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kouz's costs compare to other hematology & oncology specialists in Mission Hills?
Dr. Kouz's average Medicare payment per service is $59. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kouz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →